US OptionsDetailed Quotes

PTCT240517C34000

Watchlist

0.64
0.000.00%

15min DelayTrading May 14 10:34 ET

0.00High0.00Low

PTC Therapeutics Stock Discussion

Meltyy

May 22 15:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics(IOVA.US)$ Phase 2
$Supernus Pharmaceuticals(SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF(BINV.US)$ Phase 2a
$MorphoSys(MOR.US)$ Phase 2
$Nuvation Bio(NUVB.US)$ Phase 2
$ALX Oncology(ALXO.US)$ Phase 2
$BioXcel Therapeutics(BTAI.US)$ Phase 2
$Purple Biotech(PPBT.US)$ Phase 2
$Arcus Biosciences(RCUS.US)$ Phase 2
$Medicenna Therapeutics(MDNAF.US)$ Phase 2b
$Affimed NV(AFMD.US)$ Phase 2
$Barinthus Biotherapeutics(BRNS.US)$ Phase 2b...

mad541

May 20 20:38

$PTC Therapeutics(PTCT.US)$ just dud offering 22.87 a share get out 🔻🔻🔻🔻

Moomoo AI

Mar 3 22:56

PTC Therapeutics' low P/S ratio is seen as reasonable due to industry underperformance. However, weak revenue outlook is pressuring shares, making maintaining current prices challenging. Shareholders accept the low P/S, expecting no future revenue surprises.

There's No Escaping PTC Therapeutics, Inc.'s (NASDAQ:PTCT) Muted Revenues Despite A 27% Share Price Rise

Moomoo AI

Feb 14 22:26

Recent insider selling at PTC Therapeutics outweighs insider buying, a potential bearish sign. Despite some insider buying, the long-term outlook lacks positivity. Insider ownership suggests alignment with shareholders, but insider selling warrants caution.

PTC Therapeutics Insiders Sold US$1.1m Of Shares Suggesting Hesitancy

Moomoo AI

Nov 18, 2023 22:43

PTC Therapeutics' ongoing losses may have led to negative market view, causing a contradictory movement in the stock against the company’s revenue growth. The firm's underperformance in the past five years suggests unresolved issues. Currently, the healthcare company has five investment analysis warning signs.

PTC Therapeutics (NASDAQ:PTCT) Adds US$145m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 68%

amiable Hedgehog_758

Oct 20, 2023 02:39

$PTC Therapeutics(PTCT.US)$ 🚀🚀🚀🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥 Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- R...

GAME_DAY

Sep 15, 2023 22:59

Current watch ⚡️

$Sociedad Quimica Y Minera De Chile(SQM.US)$ $Wynn Resorts(WYNN.US)$ $Greenland Technologies(GTEC.US)$ $Iovance Biotherapeutics(IOVA.US)$ $5E Advanced(FEAM.US)$ $MicroCloud Hologram(HOLO.US)$ $AgriFORCE Growing(AGRI.US)$ $PTC Therapeutics(PTCT.US)$ $Adobe(ADBE.US)$ $ASML Holding(ASML.US)$

Erichua

Sep 15, 2023 21:24

ColumnsUS Premarket Mover

*Adobe, Canopy Growth, DoorDash, Nikola* US equities were little changed as of 8:51 a.m.
New York time, with Wall Street weighing the latest economic reports ahead of next week’s Federal Reserve decision Here are some of the biggest US movers today: Gainers:
🌟 *Canopy Growth (CGC)* shares jump 20% after the cannabis company ceased funding for BioSteel Sports Nutrition on Thursday
🌟 *Nikola (NKLA)* shares gain 15% putting the electric-vehicle maker on track to extend Thursday...

GAME_DAY

Jun 22, 2023 05:45

TOP WATCH AH + 6/22 ⚡️⚡️

$Applied Optoelectronics(AAOI.US)$ $Ault Disruptive Technologies Corporation(ADRT.US)$ $AlloVir(ALVR.US)$ $BranchOut Food(BOF.US)$ $Chemomab Therapeutics(CMMB.US)$ $Cognizant(CTSH.US)$ $Greenpro Capital(GRNQ.US)$ $IDEX Corp(IEX.US)$ $Eightco Holdings(OCTO.US)$ $ShiftPixy(PIXY.US)$ $Root Inc(ROOT.US)$ $PTC Therapeutics(PTCT.US)$ $Summit Therapeutics(SMMT.US)$ $ZoomInfo(ZI.US)$

No comment yet